Amar Basavatia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amar Basavatia has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Wolfgang A. Tomé
Montefiore Medical Center, Department of Radiation Oncology, Bronx, NY, USA; Albert Einstein College of Medicine, Institute for Onco-Physics, Bronx, NY, USA
7 shared publications Jin Shen
Radiation Oncology Montefiore Medical Center Bronx New York USA
3 shared publicationsMadhur K. Garg
Radiation Oncology Montefiore Medical Center Bronx New York USA
3 shared publications- Jing Shen
Southwest Medical University, Luzhou, China
2 shared publications - Lee C. Goddard
Radiation Oncology, Montefiore Medical Center, Bronx, USA
2 shared publications - Megha Garg
San Francisco VA Medical Center Medicine Service San Francisco California USA
2 shared publications
Latest Publications
- Open Access
- 14 April 2024
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 25 (5) , e14344
Design and implementation of automated notification systems and an electronic whiteboard for radiation therapy planning monitoring
Purpose: Radiotherapy (RT) treatment and treatment planning is a complex process prepared and delivered by a multidisciplinary team of specialists. Efficient communication and notification systems among different team members are therefore essential to ensure the safe, timely delivery of treatments to patients.Method: To address this issue, we developed and implemented automated notification systems and an electronic whiteboard to track every CT simulation, contouring task, the new‐start schedule, and physician's appointments and tasks, and notify team members of overdue and missing tasks and appointments. The electronic whiteboard was developed to have a straightforward view of current patients’ planning workflow and to help different team members coordinate with each other. The systems were implemented and have been used at our center to monitor the progress of treatment‐planning tasks for over 2 years.Results: The last‐minute plans were relatively reduced by about 40% in 2023 compared to 2021 and 2022 with a p‐value < 0.05. The overdue contouring tasks of more than 1 day decreased from 46.8% in 2019 and 33.6% in 2020 to 20%–26.4% in 2021–2023 with a p‐value < 0.05 after the implementation of the notification system. The rate of plans with 1–3 day planning time decreased by 20.31%, 39.32%, and 24.08% with a p‐value < 0.05 and the rate of plans with 1–3 day planning time due to the contouring task overdue more than 1 day decreased by 49.49%, 56.89%, and 46.52% with a p‐value < 0.05 after the implementation. The rate of outstanding appointments that are overdue by more than 7 days decreased by more than 5% with a p‐value < 0.05 following the implementation of the system.Conclusions: Our experience shows that this system requires minimal human intervention, improves the treatment planning workflow and process by reducing errors and delays in the treatment planning process, positively impacts on‐time treatment plan completion, and reduces the need for compressed or rushed treatment planning timelines.
- 14 April 2024
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 25 (5) , e14344
Open AccessDesign and implementation of automated notification systems and an electronic whiteboard for radiation therapy planning monitoring
Purpose: Radiotherapy (RT) treatment and treatment planning is a complex process prepared and delivered by a multidisciplinary team of specialists. Efficient communication and notification systems among different team members are therefore essential to ensure the safe, timely delivery of treatments to patients.Method: To address this issue, we developed and implemented automated notification systems and an electronic whiteboard to track every CT simulation, contouring task, the new‐start schedule, and physician's appointments and tasks, and notify team members of overdue and missing tasks and appointments. The electronic whiteboard was developed to have a straightforward view of current patients’ planning workflow and to help different team members coordinate with each other. The systems were implemented and have been used at our center to monitor the progress of treatment‐planning tasks for over 2 years.Results: The last‐minute plans were relatively reduced by about 40% in 2023 compared to 2021 and 2022 with a p‐value < 0.05. The overdue contouring tasks of more than 1 day decreased from 46.8% in 2019 and 33.6% in 2020 to 20%–26.4% in 2021–2023 with a p‐value < 0.05 after the implementation of the notification system. The rate of plans with 1–3 day planning time decreased by 20.31%, 39.32%, and 24.08% with a p‐value < 0.05 and the rate of plans with 1–3 day planning time due to the contouring task overdue more than 1 day decreased by 49.49%, 56.89%, and 46.52% with a p‐value < 0.05 after the implementation. The rate of outstanding appointments that are overdue by more than 7 days decreased by more than 5% with a p‐value < 0.05 following the implementation of the system.Conclusions: Our experience shows that this system requires minimal human intervention, improves the treatment planning workflow and process by reducing errors and delays in the treatment planning process, positively impacts on‐time treatment plan completion, and reduces the need for compressed or rushed treatment planning timelines.
- Open Access
- 23 April 2022
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 23 (6) , e13609
Organ‐at‐risk dose prediction using a machine learning algorithm: Clinical validation and treatment planning benefit for lung SBRT
Objective: To quantify the clinical performance of a machine learning (ML) algorithm for organ‐at‐risk (OAR) dose prediction for lung stereotactic body radiation therapy (SBRT) and estimate the treatment planning benefit from having upfront access to these dose predictions.Methods: ML models were trained using multi‐center data consisting of 209 patients previously treated with lung SBRT. Two prescription levels were investigated, 50 Gy in five fractions and 54 Gy in three fractions. Models were generated using a gradient‐boosted regression tree algorithm using grid searching with fivefold cross‐validation. Twenty patients not included in the training set were used to test OAR dose prediction performance, ten for each prescription. We also performed blinded re‐planning based on OAR dose predictions but without access to clinically delivered plans. Differences between predicted and delivered doses were assessed by root‐mean square deviation (RMSD), and statistical differences between predicted, delivered, and re‐planned doses were evaluated with one‐way analysis of variance (ANOVA) tests.Results: ANOVA tests showed no significant differences between predicted, delivered, and replanned OAR doses (all p ≥ 0.36). The RMSD was 2.9, 3.9, 4.3, and 1.7Gy for max dose to the spinal cord, great vessels, heart, and trachea, respectively, for 50 Gy in five fractions. Average improvements of 1.0, 1.4, and 2.0 Gy were seen for spinal cord, esophagus, and trachea max doses in blinded replans compared to clinically delivered plans with 54 Gy in three fractions, and 1.8, 0.7, and 1.5 Gy, respectively, for the esophagus, heart and bronchus max doses with 50 Gy in five fractions. Target coverage was similar with an average PTV V100% of 94.7% for delivered plans compared to 97.3% for blinded re‐plans for 50 Gy in five fractions, and respectively 98.4% versus 99.2% for 54 Gy in three fractions.Conclusion: This study validated ML‐based OAR dose prediction for lung SBRT, showing potential for improved OAR dose sparing and more consistent plan quality using dose predictions for patient‐specific planning guidance.
- 23 April 2022
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 23 (6) , e13609
Open AccessOrgan‐at‐risk dose prediction using a machine learning algorithm: Clinical validation and treatment planning benefit for lung SBRT
Objective: To quantify the clinical performance of a machine learning (ML) algorithm for organ‐at‐risk (OAR) dose prediction for lung stereotactic body radiation therapy (SBRT) and estimate the treatment planning benefit from having upfront access to these dose predictions.Methods: ML models were trained using multi‐center data consisting of 209 patients previously treated with lung SBRT. Two prescription levels were investigated, 50 Gy in five fractions and 54 Gy in three fractions. Models were generated using a gradient‐boosted regression tree algorithm using grid searching with fivefold cross‐validation. Twenty patients not included in the training set were used to test OAR dose prediction performance, ten for each prescription. We also performed blinded re‐planning based on OAR dose predictions but without access to clinically delivered plans. Differences between predicted and delivered doses were assessed by root‐mean square deviation (RMSD), and statistical differences between predicted, delivered, and re‐planned doses were evaluated with one‐way analysis of variance (ANOVA) tests.Results: ANOVA tests showed no significant differences between predicted, delivered, and replanned OAR doses (all p ≥ 0.36). The RMSD was 2.9, 3.9, 4.3, and 1.7Gy for max dose to the spinal cord, great vessels, heart, and trachea, respectively, for 50 Gy in five fractions. Average improvements of 1.0, 1.4, and 2.0 Gy were seen for spinal cord, esophagus, and trachea max doses in blinded replans compared to clinically delivered plans with 54 Gy in three fractions, and 1.8, 0.7, and 1.5 Gy, respectively, for the esophagus, heart and bronchus max doses with 50 Gy in five fractions. Target coverage was similar with an average PTV V100% of 94.7% for delivered plans compared to 97.3% for blinded re‐plans for 50 Gy in five fractions, and respectively 98.4% versus 99.2% for 54 Gy in three fractions.Conclusion: This study validated ML‐based OAR dose prediction for lung SBRT, showing potential for improved OAR dose sparing and more consistent plan quality using dose predictions for patient‐specific planning guidance.
- Open Access
- 8 May 2021
- Published by Springer Nature in Cureus
- Vol. 13 (5)
Comprehensive Patient-Specific Intensity-Modulated Radiation Therapy Quality Assurance Comparing Mobius3D/FX to Conventional Methods of Evaluation
To determine the appropriateness of implementing Mobius3D/FX (Varian Medical Systems, Inc., Palo Alto, CA, USA) as not only a pretreatment secondary check but as an alternative to measurement-based patient-specific intensity-modulated radiation therapy (IMRT) quality assurance (QA). Mobius3D/FX was commissioned and stock beam models were tweaked so that an independent recalculated 3D dose distribution can be obtained. Then, 50 patient-specific treatment plans for various indications were delivered across a 2D ion chamber array, radiochromic film setup, and electronic portal imager and analyzed with MobiusFX and gamma analysis. The concordance of plans scored as passing between MobiusFX and the conventional methods of QA was determined. All analyzed treatment plans passed with a gamma passing rate >90% across all conventional QA methods, most commonly using a 3%/3mm gamma criterion except for film measurements where a 5%/3mm criterion was applied. There was good agreement and concordance between MobiusFX and conventional methods when using a 3%/3mm criteria for MobiusFX, whereas a 2%/2mm criteria appeared too stringent as it failed treatment plans deemed clinically acceptable using conventional methods. Using a 50-sample subset of clinically delivered treatment plans this non-inferiority-type comparison shows Mobius3D/FX based on log file analysis to be a suitable alternative to conventional QA methods when utilizing the 3%/3mm gamma criterion. Methods based on log file analysis can provide an opportunity for resource sparing, improving the efficiency, and workflow for evaluating IMRT treatment plans.
- 8 May 2021
- Published by Springer Nature in Cureus
- Vol. 13 (5)
Open AccessComprehensive Patient-Specific Intensity-Modulated Radiation Therapy Quality Assurance Comparing Mobius3D/FX to Conventional Methods of Evaluation
To determine the appropriateness of implementing Mobius3D/FX (Varian Medical Systems, Inc., Palo Alto, CA, USA) as not only a pretreatment secondary check but as an alternative to measurement-based patient-specific intensity-modulated radiation therapy (IMRT) quality assurance (QA). Mobius3D/FX was commissioned and stock beam models were tweaked so that an independent recalculated 3D dose distribution can be obtained. Then, 50 patient-specific treatment plans for various indications were delivered across a 2D ion chamber array, radiochromic film setup, and electronic portal imager and analyzed with MobiusFX and gamma analysis. The concordance of plans scored as passing between MobiusFX and the conventional methods of QA was determined. All analyzed treatment plans passed with a gamma passing rate >90% across all conventional QA methods, most commonly using a 3%/3mm gamma criterion except for film measurements where a 5%/3mm criterion was applied. There was good agreement and concordance between MobiusFX and conventional methods when using a 3%/3mm criteria for MobiusFX, whereas a 2%/2mm criteria appeared too stringent as it failed treatment plans deemed clinically acceptable using conventional methods. Using a 50-sample subset of clinically delivered treatment plans this non-inferiority-type comparison shows Mobius3D/FX based on log file analysis to be a suitable alternative to conventional QA methods when utilizing the 3%/3mm gamma criterion. Methods based on log file analysis can provide an opportunity for resource sparing, improving the efficiency, and workflow for evaluating IMRT treatment plans.
- Open Access
- 4 May 2021
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 22 (5) , 58-68
Validation of accuracy deformable image registration contour propagation using a benchmark virtual HN phantom dataset
Virtual anatomic phantoms offer precise voxel mapping of the variation of anatomy with ground truth deformation vector fields (DVFs). Dice similarity coefficient (DSC) and mean distance to agreement (MDA) are the standard metrics for evaluating geometric contour congruence when testing deformable registration (DIR) algorithms. A HN virtual patient phantom data set was used for a kVCT‐kVCT automatic propagation contour validation study employing the Accuray DIR algorithm. Furthermore, since TomoTherapy uses MVCT images of the relevant anatomy for adaptive monitoring, the kVCT image data set quality was transformed to an MVCT image data set quality to study intermodal kVCT‐MVCT DIR accuracy. The results of the study indicate that the Accuray DIR algorithm can be expected to autopropagate HN contours adequately, on average, within tolerances recommended by TG‐132 (DSC 0.8‐0.9, MDA within voxel width). However, contours critical to dosimetric planning should always be visually proofed for accuracy. Using standard reconstruction MVCT image quality causes slightly less, but acceptable, agreement with ground truth contours.
- 4 May 2021
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 22 (5) , 58-68
Open AccessValidation of accuracy deformable image registration contour propagation using a benchmark virtual HN phantom dataset
Virtual anatomic phantoms offer precise voxel mapping of the variation of anatomy with ground truth deformation vector fields (DVFs). Dice similarity coefficient (DSC) and mean distance to agreement (MDA) are the standard metrics for evaluating geometric contour congruence when testing deformable registration (DIR) algorithms. A HN virtual patient phantom data set was used for a kVCT‐kVCT automatic propagation contour validation study employing the Accuray DIR algorithm. Furthermore, since TomoTherapy uses MVCT images of the relevant anatomy for adaptive monitoring, the kVCT image data set quality was transformed to an MVCT image data set quality to study intermodal kVCT‐MVCT DIR accuracy. The results of the study indicate that the Accuray DIR algorithm can be expected to autopropagate HN contours adequately, on average, within tolerances recommended by TG‐132 (DSC 0.8‐0.9, MDA within voxel width). However, contours critical to dosimetric planning should always be visually proofed for accuracy. Using standard reconstruction MVCT image quality causes slightly less, but acceptable, agreement with ground truth contours.
- Open Access
- 5 December 2018
- Published by Springer Nature in Cureus
- Vol. 10 (12) , e3693
Interstitial Surgical Cavity Sizing Applicators for the Treatment of the Breast Lumpectomy Cavity with Intraoperative Radiation Therapy
Surgical cavity sizing applicators were developed for utilization prior to intraoperative radiation therapy (IORT) of the breast lumpectomy cavity with the Zeiss INTRABEAM (Carl Zeiss Meditec AG, Jena, Germany) device. The use of these applicators minimizes the number of sterilizations of the treatment applicator, which is currently limited to 100 sterilizations per applicator. This maximizes the number of patients who can be treated with each applicator, resulting in cost savings for the treating institution.
- 5 December 2018
- Published by Springer Nature in Cureus
- Vol. 10 (12) , e3693
Open AccessInterstitial Surgical Cavity Sizing Applicators for the Treatment of the Breast Lumpectomy Cavity with Intraoperative Radiation Therapy
Surgical cavity sizing applicators were developed for utilization prior to intraoperative radiation therapy (IORT) of the breast lumpectomy cavity with the Zeiss INTRABEAM (Carl Zeiss Meditec AG, Jena, Germany) device. The use of these applicators minimizes the number of sterilizations of the treatment applicator, which is currently limited to 100 sterilizations per applicator. This maximizes the number of patients who can be treated with each applicator, resulting in cost savings for the treating institution.
- Open Access
- 1 May 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 123, S853
EP-1583: Quantifying Plan Quality Metrics using Conventional and Stereotactic dosimetric indices in Lung SBRT
- 1 May 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 123, S853
Open AccessEP-1583: Quantifying Plan Quality Metrics using Conventional and Stereotactic dosimetric indices in Lung SBRT
- Open Access
- 1 April 2016
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 119, S402
PO-0845: Evaluating dosimetric indices in lung SBRT for establishing treatment plan quality guidelines
- 1 April 2016
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 119, S402
Open AccessPO-0845: Evaluating dosimetric indices in lung SBRT for establishing treatment plan quality guidelines
- Open Access
- 12 February 2016
- Published by Cureus, Inc. in Cureus
- Vol. 8 (2) , e492
Right Care for the Right Patient Each and Every Time
To implement a biometric patient identification system in the field of radiation oncology. A biometric system using palm vein scanning technology has been implemented to ensure the delivery of treatment to the correct patient each and every time. By interfacing a palm vein biometrics system (PVBS) (PatientSecure®, Imprivata, Lexington, Massachusetts) with the radiation oncology patient management system (ROPMS) (ARIA®, Varian Medical Systems, Palo Alto, California) one can integrate patient check-in at the front desk and identify and open the correct treatment record of the patient at the point of care prior to the initiation of the radiation therapy treatment. The learning time for the use of the software and palm scanner was extremely short. The staff at the front desk and treatment machines learned the procedures to use, clean, and care for the device in one hour’s time. The first key to the success of the system is to have a policy and procedure in place; such a procedure was created and put in place in the department from the first day. The second key to the success is the actual hand placement on the scanner. Learning the proper placement and gently reminding patients from time to time was found to be efficient and to work well. The use of a biometric patient identification system employing palm vein technology allows one to ensure that the right care is delivered to the right patient each and every time. Documentation through the PVBS database now exists to show that this has taken place.
- 12 February 2016
- Published by Cureus, Inc. in Cureus
- Vol. 8 (2) , e492
Open AccessRight Care for the Right Patient Each and Every Time
To implement a biometric patient identification system in the field of radiation oncology. A biometric system using palm vein scanning technology has been implemented to ensure the delivery of treatment to the correct patient each and every time. By interfacing a palm vein biometrics system (PVBS) (PatientSecure®, Imprivata, Lexington, Massachusetts) with the radiation oncology patient management system (ROPMS) (ARIA®, Varian Medical Systems, Palo Alto, California) one can integrate patient check-in at the front desk and identify and open the correct treatment record of the patient at the point of care prior to the initiation of the radiation therapy treatment. The learning time for the use of the software and palm scanner was extremely short. The staff at the front desk and treatment machines learned the procedures to use, clean, and care for the device in one hour’s time. The first key to the success of the system is to have a policy and procedure in place; such a procedure was created and put in place in the department from the first day. The second key to the success is the actual hand placement on the scanner. Learning the proper placement and gently reminding patients from time to time was found to be efficient and to work well. The use of a biometric patient identification system employing palm vein technology allows one to ensure that the right care is delivered to the right patient each and every time. Documentation through the PVBS database now exists to show that this has taken place.
- 1 January 2015
- Published by Elsevier in Medical Dosimetry
- Vol. 40 (3) , 205-209
An efficient Volumetric Arc Therapy treatment planning approach for hippocampal-avoidance whole-brain radiation therapy (HA-WBRT)
- 1 January 2015
- Published by Elsevier in Medical Dosimetry
- Vol. 40 (3) , 205-209
An efficient Volumetric Arc Therapy treatment planning approach for hippocampal-avoidance whole-brain radiation therapy (HA-WBRT)